Press Releases

MARLBOROUGH, Mass., Nov. 18, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced the pricing of its previously announced public offering of 10,000,000 shares of its com

DUBLIN and BOSTON, Nov. 18, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) and Rodin Therapeutics, Inc. (Rodin) today announced that they have entered into a def

REHOVOT, Israel, Nov. 18, 2019 /PRNewswire/ -- Lavie Bio (Lavie), a subsidiary of Evogene (NASDAQ: EVGN) (TASE: EVGN), aiming to improve food quality, sustainability and agriculture productivity through the introduction of microbiome based ag-biological products, announces today phase advancement in its product development pipeline for wheat bio-stimulants. This fol

TUCSON, Ariz., Nov. 18, 2019 /PRNewswire/ -- UAVenture Capital Fund (UAVC), a Tucson-based venture capital fund dedicated to the commercialization of University of Arizona discoveries, products, technologies and services, today announced its thirteenth investment.

BOSTON and ZÜRICH, Nov. 18, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has re

BOSTON, Nov. 18, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by N

FRISCO, Texas, Nov. 18, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS), a provider of comprehensive home care services, today provided an update on the federal Centers for Medicare and Medicaid Services ("CMS") approval of the State of Illinois budgeted rate increases and its expected impact on the Company's operations in

AUSTIN, Texas, Nov. 18, 2019 /PRNewswire/ -- Superior HealthPlan will begin serving more people in Texas next year through the STAR+PLUS program. The Texas Health and Human Services Commission (HHSC) intends to award a contract that will allow Superior to expand STAR+PLUS coverage in the El Paso and

CARMIEL, Israel, Nov. 18, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, and its development and commercialization partner,

PLEASANTON, Calif., Nov. 18, 2019 /PRNewswire/ -- Today, at the ISSA Show North America 2019 annual conference, CloroxPro announced a partnership with leading non-profit Project for Public Spaces that will help advance its mission to improve public health by connecting individuals and empowering them to thrive as a community.